|
KMID : 0378019900330050065
|
|
New Medical Journal
1990 Volume.33 No. 5 p.65 ~ p.68
|
|
|
Clinical Study of Permixon on Chronic Prostatis
|
|
|
|
|
Abstract
|
|
|
A lipidosterolic extract of Serenoa Repens, Permixon was administered orally in dose of 160 mg., b.i.d. for 60 days in 31 cases of chronic prostatitis and placebo was administered orally in dose of 2 tablets, b.i.d. in 30 cases of chronic prostatitis, and following resifts were obtained.
1. In Permixon group, 26 cases (77.4%) were improved and in placebo group, 7 cases (23.3 %) were improved.
2. Symptomatically the referred pain was improved in 85.7%, frequency in 78.9%, -Drostatic secretion finding in 80.6% in permixon group but -in placebo group referred pain was improved in 37.5%, frequency in 20%, prostatic secretion finding in 26.7%.
3. Side effects of permixon were negligible.
|
|
|
KEYWORD
|
|
|
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|